A detailed long range restriction map of the region de®ned by markers D6S149 and D6S193 on chromosome 6q27 has been constructed. This was achieved by YAC cloning and contig assembling of the same region. Seven YAC clones were found to span the almost 1000 Kb region¯anked by the two markers which on the genetic map resulted to be 1.9 cM apart. With some of the characterized YAC clones we undertook a molecular cytogenetic analysis of 20 benign ovarian tumors. The rationale for this was the recent mapping to a region of chromosome 6q27,¯anked by markers D6281 and D6S133, of a locus for the SV40-mediated immortalization of human cells (SEN6 gene). Noteworthy we found that the the D6S149-D6S193 region (comprised in the larger D6S281-D6S133 physical interval) was altered in all samples analysed adding support to the occurrence of a immortalization step in this type of tumors.
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Keywords: chromosome 6q27; physical map; YAC clones; deletion; benign ovarian tumors The 6q27 region, found to be deleted in ovarian carcinomas and corresponding to loci D6S149 and D6S93 (Saito et al., 1992; Foulkes et al., 1993; Cooke et al., 1996) , was cloned by screening CEPH and ICI YAC libraries. With markers D6S149, D6S193 and D6S297 (which is located in between the previous two) used as hybridization probes or for PCR assays, several YAC clones were isolated and characterized (Figure 1 bottom). More speci®cally YACs 17IA12 and 32GF5 (ICI) were obtained by PCR screening with D6S297 speci®c primers whereas YAC clone 74E9 (CEPH) was isolated with the same procedure with primers speci®c for the polymorphic D6S149 locus. Moreover YAC clones 4HE8, 30CD7 (ICI) and 911C10 and 756H5 (CEPH) were all obtained by hybridization screening with an Alu-vector (right arm) PCR product from YAC 32GF5.
Using probes derived from YAC clones 4HE8 (probe A Figure 1 bottom) and 74E9 (probe B Figure 1 bottom) a genomic long range restriction map (from human blood lymphocytes) of the region comprised by D6S149 and D6S193 markers and extending towards both the telomere and centromere was constructed (Figure 1 top) . According to the genomic mapping data the physical distance between the above markers, estimated to be 2 cM apart, is no more than 1000 Kb. This is, on the other hand, in keeping with the telomeric position of the region bounded by them. At variance with the fairly well characterized ovarian carcinomas (Zheng et al., 1991; Iwabuchi et al., 1995; Orphanos et al., 1995; Cooke et al., 1996; Sato et al., 1991 , Saito et al., 1992 Foulkes et al., 1993; Wan et al., 1994; Tibiletti et al., 1996) very few reports have investigated the involvement of chromosome 6 and, in particular of the long arm, in benign surface epithelial ovarian tumors (BOT) (Orphanos et al., 1995) We therefore decided to exploit the information derived from the cloning of the D6S149-D6S193 region to investigate by FISH analysis its integrity in a panel of benign ovarian tumors (BOTs). Besides the above considerations the rationale for this was the recent localization to 6q27, in a region de®ned by markers D6S133 and D6S281, of a locus for SV40-mediated immortalization of human cells (Sandhu et al., 1994; Banga et al., 1997) . Assuming that a progression mechanism is at work in the tumorigenesis process leading to frank carcinomas as opposed to a dierentiation/maturation model (although this matter is still unsettled) (Liu and Nuzum, 1995; Zheng et al., 1995; Wolf et al., 1996; Salazar et al., 1997 ) the region mentioned above is expected to be altered in benign neoplasms.
The study of BOTs is a rather cumbersome task given the dramatic low occurrence of ®nding pluristrati®ed epithelium indicating an active proliferation. Out of ®fty cystic samples of BOTs available in our laboratory a meaningful investigation was possible only in twenty of them. The histopathological and conventional cytogenetic features of these benign neoplasms are summarized in Table 1 . As can be seen clonal chromosomal aberrations were detected in 17 out of 20 cases, 14 of which showed 6q deletions. The other chromosome anomalies involved were monosomy of chromosomes 20, 19, 21, 22,17 and X. The most frequent lesion in this cohort involved chromosome 6 and, in particular, terminal deletions of 6q greatly outnumbered all other cytogenetically detectable alterations. It is remarkable that in four cases with a normal karyotype (cases 1,2,18 and 19) two of them (cases 2 and 18) had 6q25-26-qter abnormalities as the sole detectable cytogenetic lesion. FISH analysis with YAC clones from the D6S149-D6S193 region in 6q27 (see map of Figure 1 , clones 17IA12, 32GF5, 30CD7,4HE8 and 74E9) as well as with YAC clones from 6q26 (clones 204B2 and 962B4; the latter is located at a more telomeric position with respect to clone 204B2 although the distance between them has not been determined yet) and 6q21-22.3 (clone 728B3, such region is already known to be the target of allelic losses in carcinomas, (Orphanos et al., 1995) showed abnormalities of the 6q27 region in eighteen out of twenty tumors. Unfortunately due to the low occurrence of mitoses not all cases could be assessed with all YAC clones available. Despite such limitations, some conclusions can be drawn from such analysis which are shown in Figure 2 . As depicted in this Figure the most Figure 1 (Top) Rare-cutter restriction map for the 1000 Kb D6S149-D6S193 genomic region. Agarose plugs of high molecular weight DNA were prepared either from blood lymphocytes or from yeast cells, digested with rare cutters according to the manufacturer's instructions (Boehringer) and fractionated in 1.5% agarose gels. Separated fragments were blotted onto nylon membranes and hybridized according to standard protocols. Probe A is a 500 bp PCR product obtained after applying the vectorette end rescue procedure to YAC 32GF5. Probe B is a 1.5 Kb restriction fragment obtained after digestion of cosmid c16-24 (D6S149) (22) (1986) . Karyotype analysis was performed using QFQ banding technique according to Mitelman (1995) . A minimum of ten metaphases were analysed. Chromosome abnormalities were described according to the recommendations of the Cancer Cytogenetics Supplement (Mitelman, 1995) . When dierent tumor cell populations were identi®ed, the chromosome complement of each population was described. Two types of probes were used (i) whole chromosome painting (WCP) for chromosome 6 digoxigenin labelled (ONCOR) (ii) YACs clones mapped to 6q26-27. The order of the YAC clones presented re¯ects their physical location along the long arm of chromosome 6 with respect to the centromere-telomere centromeric deletion boundaries are variable among the cases and are comprised between the 6q26 YAC clones 962B4 and 204B2, but, interestingly, the most telomeric YAC clone 74E9 is always present in the eleven cases that could be analysed with it (cases 3,6,8,9,10,11,12,13,14,15 and 20) . No abnormal pattern was seen with the more centromeric YAC clone 728B3 localized at 6q21-22.3, although the number of tumors where it could be tested is low (six cases). Moreover, interstitial deletions were de®ned in sixteen cases which showed deletion of clone 4HE8 (cases 3,10,11,12,13,14,15,16,19 and 20) , clone 30CD7 (cases 3,4,10,15 and 19) or both (cases 3, 10, 15 and 19) (see Figure 2 ). Noteworthy YAC clone 4HE8 is deleted in ten cases. Additionally two cases showed a transposition of clones 30CD7, 4HE8 (case 7) and 32GF5 (case 5) to a more proximal position on the long arm of chromosome 6 (data not shown). The paucity of metaphases in these latter two cases precluded a more thorough investigation of other YAC clones for the ®ne localization of the minimal region deleted in this type of tumors. However, case 3 was particularly instructive in this regard suggesting that such region seems to be located between YAC clones 32GF5 and 74E9 (see Figure 2) . According to the map presented in Figure 1 (top) The physical distance between these two clones is approximately 450 Kb and this Figure sets the minimal size of the genomic region deleted in benign ovarian tumors described in this cohort. In summary, our data seem to imply that alterations of one or more genes localized in 6q27 is one of the earliest event in the pathogenesis of these types of ovarian tumors. Similar ®ndings were also reported by (Zheng et al., 1991) who described loss of 6q27 as one of the lesions more frequently associated in tumors with a well dierentiated phenotype (grade I) in contrast to other types of chromosomal abnormalities detected in more advanced and poorly dierentiated carcinomas. Further evidence and support for an early step involvement of 6q27 is derived from studies of benign tumors of the breast where the same region was involved in one intraductal papilloma (Dietrich et al., 1995) and in one case of ®brocystic disease presenting with an interstitial deletion including 6q25 (Dal et al., 1996) .
Worth of consideration is another point suggested by our FISH results, namely the conservation of sequences corresponding to YAC 74E9 in most of the tumors that could be analysed with it (see Figure 2 ). Furthermore, a report similar to ours but focussing on ovarian carcinomas has highlighted a 300 Kb region more telomeric to the one described in this paper (¯anked by marker D6S149 and A2) as the common region of deletion in this type of tumors (Saito et al., 1997) . Taken together both sets of data seem to suggest that at least two separate and distinct loci coding for dierent growth suppressor genes are present in the subtelomeric portion of chromosome 6q. The situation may not be so simple because YAC 74E9 is no longer present upon analysis of a cohort of more than 40 ovarian carcinomas (Tibiletti and Taramelli unpublished results) . This in turn suggests that other explanations are possible although more data are clearly needed to settle this complex issue.
As already mentioned, the senescence/immortalization gene SEN6 gene was recently assigned to a region de®ned by markers D6S133 and D6S281 (Banga et al., 1997) . This is a rather large genomic interval which includes the region characterized in this report. At the present stage we cannot formally exclude that such a gene is indeed located within the D6S149-D6S193 genomic region. Work is in progress to identify such a gene and by applying cDNA selection procedures we have initiated the search of transcripts within the cloned D6S149-D6S193 region. A dozen of ESTs and two full length cDNAs were characterized so far: one codes for an extracellular ribonuclease belonging to the family of Rh/T2/S glycoprotein ribonucleases (Trubia M et al., 1997) and is located on YAC 32GF5, whereas the other codes for a G-protein-coupled receptor related to chemokine receptors (Tibiletti and Taramelli unpublished results) (independently cloned by Liao et al., 1997) which maps to YAC 4HE8.
Lastly, although it is still highly controversial whether ovarian carcinomas arise de novo or from preexistent lesions (Liu and Nuzum, 1995; Zheng et al., Wolf et al., 1996; Salazar et al., 1997) , the fact that the region where SEN6 has been mapped is deleted in benign ovarian neoplasms suggests that a possible causal link between the loss of such gene and the immortalization of a few ovarian surface epithelial cells is worth of consideration.
